The potential mechanism is that arachidonic acid can regulate CRC development through the inhibition of cyclooxygenase (COX)/lipoxygenase (LOX) and has a competitive relation to DPA in terms of COX enzyme activity.39, 42. The gene discussed is LOX; the disease is colorectal carcinoma.